IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ -- Today, Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it
will present 4 abstracts at the annual American Society for
Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.
The scheduled times (noted in local Eastern Standard Time) of
the presentations, titles and authors are as follows.
Oral presentations include:
- Patient Satisfaction Following Chin Augmentation With
Hyaluronic Acid Fillers: A Pooled Analysis
-
- Authors: Joely Kaufman,
Patricia Ogilvie, Kenneth Beer, Alexander
Rivkin, Sarah Baradaran,
Andrew Schumacher
- Presenter: Joely Kaufman,
MD
- Saturday, October
10th, 11:27
a.m.
- Treatment of Upper Facial Lines With OnabotulinumtoxinA
Results in Long-Lasting Efficacy and Patient Satisfaction
-
- Authors: Joel L. Cohen, Koenraad
De Boulle, Steven Fagien, Jean
Carruthers, Sue Ellen Cox,
Patricia Ogilvie, Julie Garcia, Sara
Sangha
- Presenter: Joel L. Cohen,
MD
- Sunday, October 11th,
10:27 a.m.
The following posters will be on display and available for the
entire length of the ASDS Virtual Annual Meeting.
- Safety, Pharmacodynamic Response, and Treatment Satisfaction
With OnabotulinumtoxinA 40 U, 60 U, and 80 U in Subjects With
Moderate to Severe Dynamic Glabellar Lines
-
- Authors: Sue Ellen Cox,
John H. Joseph, Steven Fagien,
Dee Anna Glaser, Suzanne Bruce, Edward
Lain, Steven Yoelin,
Melanie Palm, Corey S. Maas, Xiaofang
Lei, John Maltman,
Sara Sangha, Mitchell Brin
- Global Patient Perspectives on Skin Quality in Facial
Aesthetics
-
- Authors: Noëlle Sherber, Annie
Chiu, Arisa Ortiz,
Shannon Humphrey, Jeanine Downie, Sabrina
Fabi
Complete abstracts, details on presentation times and changes to
presentation dates can be found on the ASDS website. The above
listed dates are subject to change. Please
check www.asds.net for the latest information.
IMPORTANT SAFETY INFORMATION & APPROVED
USES
BOTOX® Cosmetic may cause serious side
effects that can be life threatening. Get medical help right away
if you have any of these problems any time (hours to weeks) after
injection of BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to weakening
of associated muscles, can be severe and result in loss of life.
You are at the highest risk if these problems are pre-existing
before injection. Swallowing problems may last for several
months.
- Spread of toxin effects. The effect of botulinum toxin may
affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not the same as,
or comparable to, any other botulinum toxin product.
There
has not been a confirmed serious case of spread of toxin effect
when BOTOX® Cosmetic has been used at the recommended
dose to treat frown lines, crow's feet lines, and/or forehead
lines.
BOTOX® Cosmetic may cause loss of strength or general
muscle weakness, vision problems, or dizziness within hours to
weeks of taking BOTOX® Cosmetic. If this happens, do
not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions
have been reported. They include: itching, rash, red itchy
welts, wheezing, asthma symptoms, or dizziness or feeling faint.
Get medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if you: are
allergic to any of the ingredients in BOTOX® Cosmetic
(see Medication Guide for ingredients); had an allergic reaction to
any other botulinum toxin product such as Myobloc®
(rimabotulinumtoxinB), Dysport® (abobotulinumtoxinA), or
Xeomin® (incobotulinumtoxinA); have a skin infection at
the planned injection site.
Tell your doctor about all your muscle or nerve conditions,
such as ALS or Lou Gehrig's disease,
myasthenia gravis, or Lambert-Eaton syndrome, as you may be at
increased risk of serious side effects including difficulty
swallowing and difficulty breathing from typical doses of
BOTOX® Cosmetic.
Tell your doctor about all your medical conditions,
including: plans to have surgery; had surgery on your face;
have trouble raising your eyebrows; drooping eyelids; any other
abnormal facial change; are pregnant or plan to become pregnant (it
is not known if BOTOX® Cosmetic can harm your unborn
baby); are breast-feeding or plan to (it is not known if
BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you take, including
prescription and over-the-counter medicines, vitamins, and herbal
supplements. Using BOTOX® Cosmetic with certain
other medicines may cause serious side effects. Do not start any
new medicines until you have told your doctor that you have
received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or
Xeomin® in the past (tell your doctor exactly which
product you received); have recently received an antibiotic by
injection; take muscle relaxants; take an allergy or cold medicine;
take a sleep medicine; take aspirin-like products or blood
thinners.
Other side effects of BOTOX® Cosmetic include:
dry mouth; discomfort or pain at the injection site; tiredness;
headache; neck pain; and eye problems: double vision, blurred
vision, decreased eyesight, drooping eyelids and eyebrows, swelling
of your eyelids and dry eyes.
APPROVED USES
BOTOX® Cosmetic is a
prescription medicine that is injected into muscles and used to
temporarily improve the look of moderate to severe forehead lines,
crow's feet lines, and frown lines between the eyebrows in
adults.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full Product Information including Boxed
Warning and Medication Guide.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information,
visit www.AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us at www.abbvie.com.
Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original
content:http://www.prnewswire.com/news-releases/allergan-aesthetics-to-present-data-from-4-abstracts-at-the-2020-american-society-for-dermatologic-surgery-virtual-meeting-301149140.html
SOURCE AbbVie